Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T73270 |
GSK3-IN-2
|
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
GSK3-IN-2 是一种有效的 GSK3抑制剂。 | |||
T36689 | KuWal151 | ||
Potent and selective CLK inhibitor (IC50 values are 28, 88 and 510 nM for CLK4, 1 and 2, respectively). Exhibits no significant activity at CLK3, DYRK, CDK or GSK3 at a concentration of 10 μM. Inhibits growth of a range of cancer cell lines in vitro at subnanomolar concentrations. Walter et al (2018) Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype. PLoS One 13 e0196761 PMID:29723265 | |||
T72629 |
PfGSK3/PfPK6-IN-2
|
||
PfGSK3/PfPK6-IN-2 是一种有效的 PfGSK3/PfPK6(PlasmodiumfalciparumGSK3/PK6) 双重抑制剂 (IC50分别为 172 nM 和 11 nM)。PfGSK3/PfPK6-IN-2 可用于疟疾的研究。 | |||
T35560 |
SAR502250
|
||
SAR502250 is a potent, selective, ATP competitive, orally active and brain-penetrant inhibitor of GSK3, with an IC50 of 12 nM for human GSK-3β. SAR502250 displays antidepressant-like activity. SAR502250 can be used for the research of Alzheimer’s disease (AD)[1][2]. SAR502250 (0.01-1 μM; 36 h) attenuates the Aβ25-35-induced cell death in rat embryonic hippocampal neurons[2]. SAR502250 (1-100 mg/kg; a single p.o,) attenuates tau hyperphosphorylation in the cortex and spinal cord of transgenic mic... |